Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 4

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 4
---
 common warrants will be increased such that the aggregate exercise price of a common warrant (adjusted for any exercises by a holder prior to this adjustment) will remain unchanged following such adjustment. Notwithstanding the foregoing, the number of shares potentially issuable upon exercise of the common warrants is limited by the number of available shares of authorized Common Stock; accordingly, the aggregate number of shares of Common Stock potentially issuable in this offering is limited to a total of 90,000,000 shares of Common Stock, with the number of shares of Common Stock potentially issuable upon exercise of the common warrants determined by subtracting the aggregate number of shares of Common Stock or pre-funded warrants issued in this offering from 90,000,000 shares. Each purchaser will receive a pro rata portion of such amount. As a result, the aggregate number of shares of Common Stock underlying all of the common warrants may increase from 16,666,667 up to 73,333,333 (in each case, based on an assumed public offering price of $0.48 per share), assuming full adjustment of the exercise price to the Floor Price and giving effect to the “zero exercise price” provision. In the event that we are unable to obtain Stockholder Approval, the common warrants will not be exercisable and therefore will have no value.

We are also offering to certain purchasers whose purchase of shares of Common Stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if any such purchaser so chooses, pre-funded warrants, in lieu of shares of Common Stock that would otherwise result in such purchaser’s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock. The public offering price of each pre-funded warrant and accompanying common warrant will be equal to the price at which one share of Common Stock and accompanying common warrant is sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded warrant will be $0.0001 per share. The pre-funded warrants will be immediately exercisable and may be exercised at any time until all of the pre-funded warrants are exercised in full. The pre-funded warrants and common warrants are immediately separable and will be issued separately in this offering, but must